Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology

Contributed by: Business Wire

Tags

Science

Stem Cells

Biotechnology

Research

Pharmaceutical

Health

Artificial Intelligence

Technology

Turbine

More Like This

Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical

Turbine Establishes Research Collaboration with Ono Pharmaceutical to Identify and Validate Novel Oncology Targets

AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals

Turbine Announces Collaboration to Uncover Biological Mechanisms of Drug Resistance in Hematological Cancers

Turbine Launches the World’s First Virtual Lab Using Cell Simulations

Crown Bioscience and NEXT Oncology Cement Partnership Extension

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities